Response to glycoprotein

pathway activity — cross-omics
GO:1904587Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Response to glycoprotein pathway is significantly associated with the RNA expression of multiple genes, with the LSCC cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are CD19, IGHV3-7, and CD33, each associated with the pathway in up to 5 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Response to glycoprotein activity versus CD19 in LSCC (Pearson r = 0.17).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LSCCCD19 →+1.005+0.140<.001.00135
GBMIGHV3-7 →+1.247+0.231.003.00135
GBMCD33 →+0.838+0.337<.001<.00134
BRCAP2RX1 →+0.704+0.364.002.00925
GBMMS4A6A →+1.086+0.271<.001<.00134
BRCAIL10RA →+0.785+0.369<.001.00334
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:1904587 vs CD19 — LSCC

Per-sample scatter of Response to glycoprotein activity vs CD19 in LSCC.

Explore this scatter interactively →

Exploration